Quality Level
assay
≥98.0% (T)
mp
277 °C (dec.) (lit.)
functional group
amine
InChI
1S/C2H7NO4S/c3-1-2-7-8(4,5)6/h1-3H2,(H,4,5,6)
InChI key
WSYUEVRAMDSJKL-UHFFFAOYSA-N
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
T Táira et al.
Psychopharmacology, 109(1-2), 191-197 (1992-01-01)
Long-term effects of chronic treatment with a GABA-T (GABA-transaminase) inhibitor, ethanolamine O-sulphate (EOS) (200 mg/kg/day for the postnatal days 3-21) on the binding parameters of GABAA receptors, hypothalamic monoamines and subsequent behavior were studied in Wistar rats. At the age
M Qume et al.
British journal of pharmacology, 122(3), 539-545 (1997-11-14)
1. The effects of 2, 8 and 21 day oral treatment with the specific gamma-aminobutyric acid transaminase (GABA-T) inhibitors gamma-vinyl GABA (GVG) and ethanolamine O-sulphate (EOS) on brain GABA levels, GABA-T activity, and basal and stimulated GABA release from rat
P Baud et al.
Brain research, 452(1-2), 203-211 (1988-06-14)
Locomotor activity in the rat was studied after infusion of GABAergic and enkephalinergic agonists into the nucleus basalis magnocellularis (NBM) of the forebrain. The experiments were designed to find out whether pharmacological blockade of cholinergic neurons in the NBM had
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 144525-50G | 04061832241890 |
| 144525-10G | 04061838735683 |
| 06720-500G | 04061838646866 |
| 06720-100G | 04061838646842 |
